Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CariCord is a specialized cord blood banking organization located on the University of Colorado Anschutz Medical Campus. It operates as a partnership between ClinImmune Cell Therapy and the University of Colorado, providing families with high-quality private banking services for newborn stem cells derived from cord blood and cord tissue. The company leverages ClinImmune's FDA-licensed and AABB-accredited laboratory infrastructure, which is also a major provider for the National Marrow Donor Program. By combining academic research excellence with clinical-grade processing, CariCord ensures that stored stem cells meet the highest standards for potential use in treating hematologic and genetic disorders. Its mission focuses on advancing regenerative medicine through secure cryopreservation and ongoing clinical collaboration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CariCord.